Literature DB >> 24398431

DRD3 variation associates with early-onset heroin dependence, but not specific personality traits.

Shin-Chang Kuo1, Yi-Wei Yeh1, Chun-Yen Chen1, Chang-Chih Huang2, Hsin-An Chang3, Che-Hung Yen4, Pei-Shen Ho5, Chih-Sung Liang6, Han-Wei Chou5, Ru-Band Lu7, San-Yuan Huang8.   

Abstract

Dopamine D3 receptor-mediated pathways are involved in the mechanism of addiction, and genetic factors play a role in the vulnerability to heroin dependence. The aim of this study was to examine whether the corresponding gene, DRD3, is associated with the development of heroin dependence and specific personality traits in HD patients. Eight polymorphisms in DRD3 were analyzed in 1067 unrelated Han Chinese subjects (566 heroin dependence patients and 501 controls). All participants were screened using the same assessment tool and all patients met the criteria for heroin dependence. A Tridimensional Personality Questionnaire was used to assess personality traits in 276 heroin dependence patients. In addition, heroin dependence patients were divided into 4 clinical subgroups based on age-of-onset and family history of substance abuse, to reduce the clinical heterogeneity. The rs6280 and rs9825563 variants showed association with the development of early-onset heroin dependence. The GTA haplotype frequency in the block (rs324029, rs6280, rs9825563) was significantly associated with early-onset heroin dependence (p=0.003). However, these significant associations were weaker after Bonferroni's correction. In addition, these DRD3 polymorphisms did not influence novelty seeking and harm avoidance scores in HD patients. DRD3 is possibly a genetic factor in the development of early-onset heroin dependence, but is not associated with specific personality traits in these patients among the Han Chinese population.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DRD3 gene; Heroin dependence; Personality trait; Polymorphisms

Mesh:

Substances:

Year:  2014        PMID: 24398431     DOI: 10.1016/j.pnpbp.2013.12.018

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  14 in total

1.  Addiction-related genes in gambling disorders: new insights from parallel human and pre-clinical models.

Authors:  D S S Lobo; L Aleksandrova; J Knight; D M Casey; N el-Guebaly; J N Nobrega; J L Kennedy
Journal:  Mol Psychiatry       Date:  2014-09-30       Impact factor: 15.992

2.  Dopaminergic pathway polymorphisms and heroin addiction: further support for association of CSNK1E variants.

Authors:  Orna Levran; Einat Peles; Matthew Randesi; Joel Correa da Rosa; Jurg Ott; John Rotrosen; Miriam Adelson; Mary Jeanne Kreek
Journal:  Pharmacogenomics       Date:  2014-12       Impact factor: 2.533

3.  Novelty seeking mediates the effect of DRD3 variation on onset age of amphetamine dependence in Han Chinese population.

Authors:  Shin-Chang Kuo; Yi-Wei Yeh; Chun-Yen Chen; Chang-Chih Huang; Tien-Yu Chen; Che-Hung Yen; Chih-Sung Liang; Pei-Shen Ho; Ru-Band Lu; San-Yuan Huang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-12-27       Impact factor: 5.270

4.  HUMAN STUDY COMT and DRD3 haplotype-associated pain intensity and acute care utilization in adult sickle cell disease.

Authors:  Keesha L Powell-Roach; Yingwei Yao; Margaret R Wallace; Srikar Chamala; Yenisel Cruz-Almeida; Ellie Jhun; Robert E Molokie; Zajie Jim Wang; Diana J Wilkie
Journal:  Exp Biol Med (Maywood)       Date:  2022-03-12

5.  Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson's patients.

Authors:  M Ferrari; C Comi; F Marino; L Magistrelli; F De Marchi; R Cantello; G Riboldazzi; G Bono; M Cosentino
Journal:  Eur J Clin Pharmacol       Date:  2016-08-06       Impact factor: 2.953

6.  ADHD risk alleles associated with opiate addiction: study of addicted parents and their children.

Authors:  Asher Ornoy; Victoria Finkel-Pekarsky; Einat Peles; Miriam Adelson; Shaul Schreiber; P Richard Ebstein
Journal:  Pediatr Res       Date:  2016-04-11       Impact factor: 3.756

7.  In Search of Reward Deficiency Syndrome (RDS)-free Controls: The "Holy Grail" in Genetic Addiction Risk Testing.

Authors:  Kenneth Blum; David Baron; Lisa Lott; Jessica V Ponce; David Siwicki; Brent Boyett; Bruce Steinberg; Edward J Modestino; Lyle Fried; Mary Hauser; Thomas Simpatico; Bill W Downs; Thomas McLaughlin; Raju Hajela; Rajendra D Badgaiyan
Journal:  Curr Psychopharmacol       Date:  2020

8.  Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis.

Authors:  Thomas M Keck; William S John; Paul W Czoty; Michael A Nader; Amy Hauck Newman
Journal:  J Med Chem       Date:  2015-03-31       Impact factor: 7.446

9.  A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizers.

Authors:  Rafael B R León-Cachón; Jorge A Ascacio-Martínez; María E Gamino-Peña; Ricardo M Cerda-Flores; Irene Meester; Hugo L Gallardo-Blanco; Magdalena Gómez-Silva; Everardo Piñeyro-Garza; Hugo A Barrera-Saldaña
Journal:  BMC Cancer       Date:  2016-02-08       Impact factor: 4.430

Review 10.  Abnormalities of Dopamine D3 Receptor Signaling in the Diseased Brain.

Authors:  G Aleph Prieto
Journal:  J Cent Nerv Syst Dis       Date:  2017-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.